Neelapu, S. S., Chavez, J. C., Sehgal, A. R., Epperla, N., Ulrickson, M. L., Bachy, E., Munshi, P. N., Casulo, C., Maloney, D. G., de Vos, S., Reshef, R., Leslie, L. A., Oluwole, O. O., Yakoub-Agha, I., Khanal, R., Rosenblatt, J. D., Peng, W., Lui, C., Wulff, J., … Jacobson, C. A. (2023). Axicabtagene Ciloleucel (Axi-Cel) in Patients with Relapsed/Refractory Indolent Non-Hodgkin Lymphoma: 4-Year Follow-up from the Phase 2 ZUMA-5 Trial. Blood, 142(Supplement 1), 4868–4868. https://doi.org/10.1182/blood-2023-174914
Subjects:
Chimeric Antigen Receptor T Cell Therapy
(OpenAlex Topic)
Immunogenicity of Biosimilar Therapeutics in Drug Development
(OpenAlex Topic)
Publication Type:
Article
Unique ID:
10.1182/blood-2023-174914
Journal:
Publication Date:
Data Source:
OpenAlex
Source Link: